Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nyansa was a network analytics company that specialized in providing visibility and performance monitoring for enterprise networks, particularly in complex environments like healthcare and education. Its flagship platform, Voyance, utilized artificial intelligence and machine learning to analyze network traffic and user experience across wired and wireless infrastructures. By correlating data from various network layers, Nyansa helped IT teams proactively identify and resolve connectivity issues. The company's technology was widely adopted by large-scale organizations to ensure the reliability of critical digital services. In early 2020, Nyansa was acquired by VMware to enhance its software-defined networking and edge computing portfolio.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nyansa.